You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peripheral T-cell lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Analysis of Lipids in Human Milk at Different Gestational Ages

Recruiting
  • Breast Milk Collection
  • Breastfeeding
  • Salerno, Naples, Italy
  • +1 more
Aug 13, 2023

Enteric Neural Precursor Cells (ENPC) in the Human Gut

Recruiting
  • Gastrointestinal Dysmotility
  • Endoscopic procedure
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
Mar 8, 2022

DLBCL Trial (Tafasitamab, 12 mg/kg. 4 week cycles: weekly (Cycle 1-3) to bi-weekly (Cycle 4 onwards), loading dose Cycle 1, day

Approved for marketing
  • DLBCL
  • Tafasitamab, 12 mg/kg. 4 week cycles: weekly (Cycle 1-3) to bi-weekly (Cycle 4 onwards), loading dose Cycle 1, day 4. Cycle 4 onwards day 1, day 15 until disease progression
  • (no location specified)
Aug 26, 2020

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Laboratory Biomarker Analysis, Lenalidomide,

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 1, 2021

Generalized Anxiety Disorder Trial in Omaha (Empower Neuromodulation System)

Recruiting
  • Generalized Anxiety Disorder
  • Empower Neuromodulation System
  • Omaha, Nebraska
    University of Nebraska Medical Center
Oct 4, 2021

Allogenic Granulocyte Donation Trial run by the National Institutes of Health Clinical Center (CC) (Filgrastim, Dexamethasone)

Recruiting
  • Allogeneic Granulocyte Donation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 7, 2023

Prostate Cancer Trial in Boston (Radium-223, Pembrolizumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 31, 2022

Tumors, Fatigue Trial in Memphis (Bright White Light, Dim Red Light)

Completed
  • Neoplasms
  • Fatigue
  • Bright White Light
  • Dim Red Light
  • Memphis, Tennessee
    St . Jude Children's Research Hospital
May 3, 2022

Generation of Antigen-specific T-lymphocyte Cell Lines From

Terminated
  • Healthy
  • Leukapheresis
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 2, 2021

Multiple Myeloma, Relapsed and Refractory Multiple Myeloma Trial in Chengdu (HG146)

Recruiting
  • Multiple Myeloma
  • Relapsed and Refractory Multiple Myeloma
  • Chengdu, Sichuan, China
    HitGen Inc
Mar 16, 2022

Oxygen Toxicity, Anesthesia; Adverse Effect Trial in Milano (LUS-guided choice of Peep, Standard choice of Peep)

Not yet recruiting
  • Oxygen Toxicity
  • Anesthesia; Adverse Effect
  • LUS-guided choice of Peep
  • Standard choice of Peep
  • Milano, Italy
    Vittore Buzzi Cildren's Hospital
Feb 18, 2023

Liver Transplant Rejection Trial in Chicago (Erythropoietin)

Recruiting
  • Liver Transplant Rejection
  • Chicago, Illinois
    Northwestern University
Apr 5, 2022

Breast Cancer, Peripheral Neuropathy, Cardiac Toxicities Trial in Tanta (Silymarin, Placebo)

Enrolling by invitation
  • Breast Cancer
  • +4 more
  • Tanta, Egypt
    Tanta university
Oct 22, 2022

Non-squamous Non-small-cell Lung Cancer, EGFR Activating Mutation Trial in Japan (Pembrolizumab, Lenvatinib, Carboplatin)

Recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • EGFR Activating Mutation
  • Urayasu, Chiba, Japan
  • +9 more
Jul 19, 2022

Metastatic Non Small Cell Lung Cancer Trial in Raleigh (C-TIL051)

Not yet recruiting
  • Metastatic Non Small Cell Lung Cancer
  • C-TIL051
  • Raleigh, North Carolina
    Duke Cancer Institute
Jan 6, 2023

Ischemic Stroke Trial (Menthol, Placebo)

Not yet recruiting
  • Ischemic Stroke
  • (no location specified)
May 25, 2023

Carfilzomib in Patients With Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • Odense, Denmark
    Odense University Hospital
Dec 20, 2022

Metastatic Clear Cell Renal Cell Carcinoma Trial in Dallas (Nivolumab, SAbR)

Terminated
Has Results
  • Metastatic Clear Cell Renal Cell Carcinoma
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jul 12, 2022

Advanced NSCLC Trial in New Haven (NC318, Pembrolizumab)

Recruiting
  • Advanced Non-small Cell Lung Cancer
  • New Haven, Connecticut
    Yale University
May 9, 2022

Head and Neck Squamous Cell Carcinoma Trial in Dallas (Intensity modulated radiation therapy (IMRT))

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Intensity modulated radiation therapy (IMRT)
  • Dallas, Texas
    University of Texas Southwestern Medical Center - Dallas
Nov 18, 2022

Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

Not yet recruiting
  • Advanced Esophageal Squamous Carcinoma With Oligometastases
  • simultaneous with radiotherapy
  • synchronous with radiotherapy
  • (no location specified)
Nov 16, 2023

Arbovirus Infections, Zika, Dengue Trial in Dumbéa Sur Mer (Blood sample collection)

Recruiting
  • Arbovirus Infections
  • +3 more
  • Blood sample collection
  • Dumbéa Sur Mer, New Caledonia
    Centre Hospitalier Territorial de Nouvelle-Calédonie
Oct 6, 2022

Study of the Metabolism in the Lymphatic Niche of CLL

Recruiting
  • CLL
  • NO intervention
  • Nice, France
    Nice University Hospital
Nov 2, 2022

Metastatic Colorectal Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Canada,

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Durvalumab
  • +2 more
  • Phoenix, Arizona
  • +41 more
Jul 16, 2022

Non Small Cell Lung Cancer Metastatic Trial in Worldwide (Osimertinib, Bevacizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Dublin, Ireland
  • +24 more
Aug 23, 2022